PMID: 15328711Aug 27, 2004Paper

Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans

Journal of the American Veterinary Medical Association
Mark R SannesJames R Johnson

Abstract

To assess the prevalence and patterns of antimicrobial resistance among Escherichia coli strains isolated from the urine of women with cystitis or pyelonephritis and from fecal samples from dogs and healthy humans. Cross-sectional survey. Escherichia coli isolates from 82 women with cystitis, 170 women with pyelonephritis, 45 dogs, and 76 healthy human volunteers. Susceptibility to 12 antimicrobial agents was determined by means of disk diffusion testing as specified by the NCCLS. Overall, the 4 most common antimicrobial resistance patterns were resistance to ampicillin, sulfisoxazole, trimethoprim, and trimethoprim-sulfamethoxazole (n = 45 [12% of all isolates]); ampicillin alone (33 [9%]); ampicillin and sulfisoxazole (29 [8%]); and sulfisoxazole alone (14 [4%]). None of the isolates were resistant to ceftazidime, ciprofloxacin, nitrofurantoin, or piperacillin-tazobactam. Resistance was significantly more common and extensive among isolates from women with cystitis or pyelonephritis than among isolates from healthy humans or dogs. Resistance was least common among isolates from dogs. The only resistance phenotype that was more common among canine isolates than human isolates was resistance to sulfisoxazole alone. Results sugg...Continue Reading

References

Jan 1, 1991·Clinical Microbiology Reviews·J R Johnson
Mar 1, 1973·Antimicrobial Agents and Chemotherapy·V J BoyleR W Ross
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W WarrenW E Stamm
Feb 17, 2001·Infection and Immunity·J R JohnsonP Delavari
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K GuptaW E Stamm
Jul 20, 2002·Journal of the American Veterinary Medical Association·Cara L CookeDwight C Hirsh
Sep 17, 2002·The Journal of Infectious Diseases·Jordi VilaJosep Mensa

❮ Previous
Next ❯

Citations

Feb 18, 2011·Acta Veterinaria Scandinavica·Kazuki HaradaToshio Takahashi
Sep 5, 2006·Journal of the American Veterinary Medical Association·Jennifer Ogeer-GylesPatrick Boerlin
Sep 21, 2006·The Veterinary Clinics of North America. Small Animal Practice·Cyril R Clarke
Dec 9, 2010·Tropical Medicine & International Health : TM & IH·Kathleen HollowayUNKNOWN Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group
Jul 10, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F JauréguyO Lortholary
Dec 15, 2016·Turkish Journal of Medical Sciences·Betül GiraySabire Şöhret Aydemir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.